Low-dose ketamine side effects: what to expect in a session and over a course

Clinical sections reviewed by Dr Christopher Gauci, MD MRCS(Ed) EDAIC

Black and white: doctor holding a tablet

At a low dose, most of ketamine’s side effects come during the session and fade within a couple of hours of it. The ones you are most likely to notice:

  • Feeling strange or unreal, often with a sense of distance from your body
  • Drowsiness and dizziness
  • Poor coordination and unsteadiness
  • Blurred vision
  • Nausea
  • A rise in blood pressure and pulse while the dose is working

The first four were the most common effects in the four hours after 205 infusions of 0.5 mg/kg in three depression trials (Wan and colleagues, 2015, Journal of Clinical Psychiatry). The ketamine service at Oxford Health NHS Foundation Trust adds nausea or vomiting, headache, anxiety and ringing in the ears to its list of brief effects, along with feeling tired for the rest of the day after treatment.

One thing changes the answer more than the dose. Low dose describes two different ways of taking ketamine: a measured dose given by a clinician in a room, or lozenges taken at home on a telehealth plan. Within one session the effects look much the same. What differs is the number of doses, the weeks they spread over, and who is keeping count.

What happens at a low dose: during the session and in the first day


During the session. Dissociation, a sense of detachment from the body or surroundings, is part of the effect and not an accident. It is also the part people find hardest to picture in advance. Common alongside it: dizziness, nausea, blurred or double vision, sleepiness, headache, unsteadiness, and a temporary rise in blood pressure and heart rate. The strongest effects pass within about an hour, and the rest usually settle within two. That is why time under observation after dosing is standard.

The rest of that day. Tiredness, mild disorientation and emotional rawness are common. Driving is out until the next day, after a full night’s sleep. Big decisions are better left alone.

With repeated use. Bladder damage is the most serious known consequence of long-term ketamine exposure: urgency, pain on passing water, a bladder that holds less, and in severe cases injury that does not reverse. It is documented mainly in heavy frequent recreational use, at doses and frequencies far above supervised treatment. This is why urinary symptoms are asked about at every review, and why a course has a defined end rather than running indefinitely.

Dependence and craving are recognised risks. Ketamine is a controlled drug with established misuse potential, which is why supervised dosing, a course with a defined end, and limits on take-home supply exist.

Liver enzyme changes turn up occasionally with repeated exposure, and call for monitoring rather than alarm.

Questions about long-term effects on memory and thinking from repeated therapeutic use remain open. The studies that exist do not run long enough to answer that, and a service claiming otherwise is guessing.

What keeps the risk manageable. Screening that turns people away, medical supervision during dosing, blood pressure checks, a course with a defined end instead of indefinite use, and review of bladder and mood symptoms between sessions.

Checked for medical accuracy by Dr Christopher Gauci, MD MRCS(Ed) EDAIC on 1 October 2026. The check covers this section. Everything else on the page is written by our editorial team and verified against primary sources.

If something is wrong now. Pain when passing urine, blood in it, or needing to go much more often, during or after any course: contact your own doctor the same day. Call emergency services if the pain is severe or you cannot pass urine.

How long the washed-out feeling lasts is covered in how long ketamine takes to wear off.

Why salivation, nausea and a blood pressure rise are listed separately

Most effects on the list are felt from the inside. These three show from the outside, so they are the ones the person sitting with you can see and act on.

Salivation. This one comes from the anaesthesia label rather than from the depression trials, which is why it is not in the list at the top. The US prescribing information for injectable ketamine advises a drug that dries secretions before induction, at doses many times higher than a depression dose (Ketalar label, DailyMed). At a low dose it is the least likely of the three. A clinician is in the room for the whole session, so a filling mouth is something you can say out loud at the time.

Nausea. It is common enough that the Oxford service lists it with vomiting among its brief effects. Having felt sick after anaesthesia or after an earlier session is worth saying before the next dose.

Blood pressure and pulse. About a third of the 97 people in the pooled trials had changes large enough to meet the studies’ own thresholds (Wan and colleagues, 2015). How large the rise usually is and how long it lasts has its own page. Take a few home readings in the week before and bring them with you.

Two different low doses: a clinic dose below anaesthesia and a home subscription

The clinic dose. Sub-anaesthetic means below the surgical amount, where the label starts at 1 mg/kg into a vein (Ketalar label). Depression research mostly uses 0.5 mg/kg over 40 minutes (Wan and colleagues, 2015).

The home dose. Lozenges, called troches, held under the tongue at home. The largest study of this format followed 1,247 people through four weeks of telehealth treatment, written by people working for the provider itself (Hull and colleagues, 2022, Journal of Affective Disorders). Six stopped early: four for side effects or a clinician’s decision, two after adverse events.

Clinic dose Home dose
What it is 0.5 mg/kg into a vein over 40 minutes in most depression research (Wan and colleagues, 2015) Lozenges held under the tongue, prescribed after a video consultation
Who watches you A clinician gives it and stays until you are steady Monitoring at a distance (Hull and colleagues, 2022)
What decides the risk What happened in that one session How many doses, over how many weeks, and who keeps count

The figures on this page come from infusions into a vein, not the injection into a muscle used in our own week. How troches and tablets are used for depression covers the home format.

What is available in the US, UK and EU, and how the regimes differ

United States. Clinics give infusions and injections off-label, and telehealth services prescribe lozenges for home use. The Canadian CANMAT task force rated a single infusion into a vein the best-supported form, oral forms among the least (Swainson and colleagues, 2021, Canadian Journal of Psychiatry).

United Kingdom. The Oxford Health NHS Foundation Trust gives infusions in clinic, self-pay unless a trust consultant refers you. Who may prescribe it, and in what form, is on the page on whether ketamine therapy is legal.

European Union. Rules are national, and the same page covers them. What changes your risk anywhere is the route and who is with you while the dose works.

Why risk works differently in a clinic and on a home subscription: dose against frequency and length

Some risks follow the size of a single dose, others how often doses come and for how many weeks, which is why one low dose carries different risk in the two formats.

What follows the dose. In the dose-ranging trial of single doses from 0.1 to 1.0 mg/kg, dissociation and short blood pressure rises were greater at higher doses (Fava and colleagues, 2020, Molecular Psychiatry).

What follows the count. A 2025 review of bladder problems on long-term treatment named four potential risk factors: higher dose, more frequent doses, longer course, and ketamine by mouth (Andrade, 2025, Journal of Clinical Psychiatry). It found no convincing evidence that bladder disease arises in treatment: across 14 randomised trials urinary symptoms differed little between ketamine and comparison arms.

Bladder and liver load adds up over a course rather than a session, and what that means for a course packed into one week

A course held in one week puts sessions closer together than a weekly series, but its length stays short, unlike daily lozenges taken for months.

A 2025 review of 27 treatment studies found urinary symptoms in 0% to 24.5% of patients, mostly mild or moderate, and on the limited data treatment did not appear to raise that risk, though few studies ran long (Kerr-Gaffney and colleagues, 2025, Journal of Psychopharmacology). Serious cases come from a different population: the US label lists cystitis, reduced bladder capacity and blocked tubes from the kidneys with long-term use or abuse (Ketalar label, section 5.7), and the Oxford service puts that damage at illegal use above a gram a day, far above any treatment dose.

For the liver, the same label advises tests when a plan with repeated dosing starts and while it runs: long-term use has produced scarring of the bile ducts, which can reverse once ketamine stops (section 5.6). Which side effects belong to a treatment dose reads both warnings for a course. Ask whether liver tests are part of your course, and when.

Where the claim that side effects are mild and brief comes from

A US National Institutes of Health headline sums up the short-term picture: side effects mild, brief with single antidepressant dose of intravenous ketamine. It announced a pooled analysis of 188 people from five studies at the National Institute of Mental Health, 25 of them healthy volunteers, each given one infusion and asked about side effects in a set way. Most effects peaked within an hour and were gone by two hours, and nothing lasting turned up over about three months (Acevedo-Diaz and colleagues, 2020, Journal of Affective Disorders).

The authors named the limits themselves. A single infusion says little about other schedules, and the study had no formal measures of effects on thinking, the bladder or the potential for misuse. A 2018 review of 60 studies found the same gap across the field: side effects after one dose were well described, while repeated dosing and long-term safety had been little assessed (Short and colleagues, 2018, Lancet Psychiatry).

So the headline holds for one supervised infusion in a research unit. It does not cover a daily lozenge in month three. When a service quotes it, ask which schedule its own data come from, and compare it with how a week of sessions under doctors is organised.

What is measured during a session and between sessions, and what gets reported before the next dose

A session is watched with numbers and with scales: blood pressure and pulse through each infusion, dissociation on a clinician-rated scale. Between sessions the checks thin out to a questionnaire or a call. Before the next dose, a difficult session, a lost next day or new bladder symptoms are what the team needs to hear.

During a session. In the trials behind these figures, blood pressure and pulse were tracked through each infusion. Dissociation was scored on a clinician-rated scale, and in the NIH analysis higher scores tracked with the dissociative side effects people reported. In the pooled trials, 4 of 205 infusions were stopped because of side effects (Wan and colleagues, 2015).

What gets reported. Dissociation and blood pressure are both measured while the dose is working. A difficult session, a next day spent unable to function, or new bladder symptoms are worth writing down and reporting before the next dose.

Between sessions. The Oxford service says it does not routinely measure blood pressure after the first infusion unless you ask, and that liver tests are not routine because liver damage is rare. On a home plan the checks are usually a questionnaire or a video call.

Between sessions, note your mood, your sleep, anything unusual when passing urine, and how the day after went. For long-term treatment, the 2025 review advises drinking plenty and passing urine often on dosing days, and a urine test every two to four weeks (Andrade, 2025). When you compare services, ask who measures your blood pressure and how often. If you cannot get an answer, the team will talk it through with you.

A week under medical supervision in Malta: how it differs from an outpatient visit

During our week in Malta, the doctor who decides your dose stays for it. The main form is an injection into a muscle, and another route is possible if the doctors decide on it. The anaesthetist, Dr Christopher Gauci, and the consultant psychiatrist, Dr Peter Muscat, are the same all week, so the person deciding your next dose saw how your last one went.

After an outpatient visit you go home the same day, to the same job and the same house, and the next dose comes a week or more later. On a home plan, the dose is taken without anyone in the room. In our week the day after a session is kept free, a therapist works with you between sessions, and the dosing ends when the week does. How the week on the island is organised is set out in full.

Seven weeks, one team

Weeks 1-3 · online

Preparation

Three online sessions with the team who will be with you on the island: what you want from the week, how you live, and how the sessions themselves go.

Week 4 · Malta

Residential week

A medical assessment with the doctor on arrival decides how many ketamine-assisted sessions you have and on which days. A doctor and a nurse are with you through each session. Between sessions, one-to-one therapy and group integration with the other guests. You leave with your integration plan in writing.

Weeks 5-7 · online

Integration

Three online integration sessions with the same team, once you are home.

DetailMaximum four guests. Individual ketamine sessions, group integration with the other guests. How the programme is built

A week in Malta where every dose is given with a doctor in the room

The doctor who sets your sessions stays for each one, and dosing ends with the week. Start with a short form and a call, and two doctors decide at the medical assessment whether the week fits you, before you pay for the programme.

No payment and no booking at this step.

Common questions

What are the side effects of low-dose ketamine?

During the session: feeling strange or unreal, drowsiness, dizziness, poor coordination, blurred vision, nausea, and a short rise in blood pressure and pulse. Most pass within two hours, and the Oxford service also lists feeling tired for the rest of that day. Keep a note of each dose and how you felt the next day, so the prescriber has more than memory to go on.

Is a lower dose safer than a standard dose?

Within one session, yes for some effects: in a 99-person trial, dissociation and short blood pressure rises were greater at higher doses (Fava and colleagues, 2020). Over a course, the 2025 review named more frequent dosing, a longer course and the oral route alongside dose as potential risk factors, so a low dose taken daily is not automatically the safer plan. Ask how many doses your plan includes in total, and bring that number to a first call with the team.

Does ketamine still work at a lower dose?

In the same trial, 0.5 and 1.0 mg/kg into a vein showed an effect against the comparison drug, while the lower doses gave no clear or consistent evidence of benefit (Fava and colleagues, 2020). How a dose is set and adjusted between sessions explains how a prescriber settles on a number.

What is considered a very low dose of ketamine?

In depression research, doses below the standard 0.5 mg/kg into a vein, such as the 0.1 and 0.2 mg/kg arms of the dose-ranging trial (Fava and colleagues, 2020). For comparison, anaesthesia starts at 1 mg/kg and can go to 4.5 mg/kg (Ketalar label). For your own dose, start with a short form and a call.

In short

Ask two questions about any low dose of ketamine: what it does in one session, and how many sessions there will be. The first answer is short. Expect an hour or two of feeling strange, dizzy or sick, with your blood pressure up, and a tired rest of the day. The second answer is where the bladder and liver questions sit, because how often and for how long count alongside the dose, and a home plan of daily lozenges can be low on the dose and high on the rest. Keep your own record of doses and of anything unusual when passing urine, and choose a format where someone measures you during the dose.